Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome

The pharmacological treatment strategies for acute coronary syndrome (ACS) in recent years are constantly evolving to develop more potent antithrombotic agents, as reflected by the introduction of more novel P2Y(12) receptor inhibitors and anticoagulants to reduce the ischemic risk among ACS patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvarajah, Abi, Tavenier, Anne H., Fabris, Enrico, van Leeuwen, Maarten A. H., Hermanides, Renicus S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573364/
https://www.ncbi.nlm.nih.gov/pubmed/36233469
http://dx.doi.org/10.3390/jcm11195605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573364/
https://www.ncbi.nlm.nih.gov/pubmed/36233469
http://dx.doi.org/10.3390/jcm11195605

Ejemplares similares